Clinical Trial Update: Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial completed in 2019 evaluating management of pasireotide-induced hyperglycemia in adults with Cushing's disease or acromegaly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Cushing Disease

Drugs mentioned

• Pasireotide (pasireotide)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cushing's Disease, Acromegaly | Phase 4 | Status: COMPLETED | Results posted: 2019-05-29